Renal Targeting: Peptide-Based Drug Delivery to Proximal Tubule Cells

Bioconjugate Chemistry

Volumn 27, Issue 4, 2016, Pages 1050-1057

  Wischnjow, Artjom ^a   Sarko, Dikran ^a   Janzer, Maria ^a,b   Kaufman, Christina ^a   Beijer, Barbro ^a   Brings, Sebastian ^a   Haberkorn, Uwe ^a   Larbig, Gregor ^b   Kübelbeck, Armin ^b   Mier, Walter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b MERCK KGAA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; MOLECULAR BIOLOGY; PEPTIDES; TARGETED DRUG DELIVERY;

ATTRACTIVE STRATEGIES; DRUG CARRIER; DRUG EFFICACY; DRUG-TARGETING; PEPTIDE SEQUENCES; PROXIMAL TUBULES; RENAL TARGETING; RENAL TISSUE; SIDE EFFECT; TARGETING PEPTIDES;

ANTIBIOTICS;

CIPROFLOXACIN; CREATININE; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; MEGALIN; POLYLYSINE; SYNTHETIC PEPTIDE; PEPTIDE;

ACIDITY; ALKALINITY; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEIODINATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG TOLERABILITY; ENDOCYTOSIS; FEMALE; GAMMA SCINTIGRAPHY; HIGH TEMPERATURE; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; KIDNEY CORTEX; KIDNEY PROXIMAL TUBULE; KIDNEY SCINTISCANNING; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; POSITRON EMISSION TOMOGRAPHY; RADIOIODINATION; RENAL CLEARANCE; SOLID PHASE SYNTHESIS; UREA NITROGEN BLOOD LEVEL; AGED; ANIMAL; DRUG EFFECTS; HUMAN;

AGED; ANIMALS; HUMANS; KIDNEY TUBULES, PROXIMAL; MICE; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY;

EID: 84965045971     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.6b00057     Document Type: Article

References (39)

1. Zhang, J., Tian, Q., Yung Chan, S., Chuen Li, S., Zhou, S., Duan, W., and Zhu, Y.-Z. (2005) Metabolism and transport of oxazaphosphorines and the clinical implications Drug Metab. Rev. 37, 611-703 10.1080/03602530500364023
2. Vegt, E., de Jong, M., Wetzels, J. F. M., Masereeuw, R., Melis, M., Oyen, W. J. G., Gotthardt, M., and Boerman, O. C. (2010) Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention J. Nucl. Med. 51, 1049-58 10.2967/jnumed.110.075101
3. Gotthardt, M. (2010) Radiogene Nephropathie Nuklearmedizin 49, 59-63
4. Lin, Y., Li, Y., Wang, X., Gong, T., Zhang, L., and Sun, X. (2013) Targeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamine J. Controlled Release 167, 148-56 10.1016/j.jconrel.2013.02.001
5. Rajendran, L., Knolker, H. J., and Simons, K. (2010) Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discovery 9, 29-42 10.1038/nrd2897
6. de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., Goldsberry, A., Houser, M., Krauth, M., and Lambers Heerspink, H. J. et al. 2013, Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease N. Engl. J. Med. 369, 2492-2503 10.1056/NEJMoa1306033
7. Chin, M. P., Wrolstad, D., Bakris, G. L., Chertow, G. M., de Zeeuw, D., Goldsberry, A., Linde, P. G., McCullough, P. A., McMurray, J. J., and Wittes, J. et al. 2014, Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl J. Card. Failure 20, 953-958 10.1016/j.cardfail.2014.10.001
8. Perez-Gomez, M. V., Sanchez-Niño, M. D., Sanz, A. B., Martín-Cleary, C., Ruiz-Ortega, M., Egido, J., Navarro-González, J. F., Ortiz, A., and Fernandez-Fernandez, B. (2015) Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade J. Clin. Med. 4, 1325-1347 10.3390/jcm4061325
9. de Zeeuw, D., Agarwal, R., Amdahl, M., Audhya, P., Coyne, D., Garimella, T., Parving, H.-H., Pritchett, Y., Remuzzi, G., and Ritz, E. (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial Lancet 376, 1543-1551 10.1016/S0140-6736(10)61032-X
10. Delanaye, P., Mariat, C., Krzesinski, J.-M., and Cavalier, E. (2011) Paricalcitol for reduction of albuminuria in diabetes Lancet 377, 635 10.1016/S0140-6736(11)60222-5
11. Mann, J. F. E., Green, D., Jamerson, K., Ruilope, L. M., Kuranoff, S. J., Littke, T., Viberti, G., and and for the, A. S. G. (2010) Avosentan for Overt Diabetic Nephropathy J. Am. Soc. Nephrol. 21, 527-535 10.1681/ASN.2009060593
12. Serra, A. L., Poster, D., Kistler, A. D., Krauer, F., Raina, S., Young, J., Rentsch, K. M., Spanaus, K. S., Senn, O., and Kristanto, P. et al. 2010, Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease N. Engl. J. Med. 363, 820-829 10.1056/NEJMoa0907419
13. Walz, G., Budde, K., Mannaa, M., Nürnberger, J., Wanner, C., Sommerer, C., Kunzendorf, U., Banas, B., Hörl, W. H., and Obermüller, N. et al. 2010, Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease N. Engl. J. Med. 363, 830-840 10.1056/NEJMoa1003491
14. Kamada, H., Tsutsumi, Y., Sato-Kamada, K., Yamamoto, Y., Yoshioka, Y., Okamoto, T., Nakagawa, S., Nagata, S., and Mayumi, T. (2003) Synthesis of a poly(vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting Nat. Biotechnol. 21, 399-404 10.1038/nbt798
15. Yuan, Z.-X., Sun, X., Gong, T., Ding, H., Fu, Y., and Zhang, Z.-R. (2007) Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier J. Drug Targeting 15, 269-278 10.1080/10611860701289875
16. Zhang, Q., Fu, Y., Liu, R., Gong, T., Sun, X., and Zhang, Z.-R. (2014) Renal-specific delivery of prednisolone-folate conjugates for renal ischemia/reperfusion injury RSC Adv. 4, 50828-50831 10.1039/C4RA11160E
17. Franssen, E. F., van Amsterdam, R. M., Visser, J., Moolenaar, F., de Zeeuw, D., and Meijer, D. F. (1991) Low Molecular Weight Proteins as Carriers for Renal Drug Targeting: Naproxen-Lysozyme Pharm. Res. 8, 1223-1230 10.1023/A:1015835325321
18. Christensen, E. I. and Birn, H. (2001) Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule Am. J. Physiol.: Renal physiol. 280, F562-73
19. Christensen, E. I. and Nielsen, S. (1991) Structural and functional features of protein handling in the kidney proximal tubule Semin. Nephrol. 11, 414-39
20. Guo, Q., Wang, H., Zhao, Y., Wang, H., Zeng, F., Hua, H., Xu, Q., and Huang, Y. (2013) Cell-penetrating albumin conjugates for enhanced doxorubicin delivery Polym. Chem. 4, 4584 10.1039/c3py00742a
21. Zhang, Z., Zheng, Q., Han, J., Gao, G., Liu, J., Gong, T., Gu, Z., Huang, Y., Sun, X., and He, Q. (2009) The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells Biomaterials 30, 1372-1381 10.1016/j.biomaterials.2008.11.035
22. Haas, M., Kluppel, A. C., Wartna, E. S., Moolenaar, F., Meijer, D. K., de Jong, P. E., and de Zeeuw, D. (1997) Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo Kidney Int. 52, 1693-9 10.1038/ki.1997.504
23. Windt, W. a. K. M., Prakash, J., Kok, R. J., Moolenaar, F., Kluppel, C. A., de Zeeuw, D., van Dokkum, R. P. E., and Henning, R. H. (2004) Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis JRAAS 5, 197-202 10.3317/jraas.2004.040
24. Haverdings, R. F. G., Haas, M., Greupink, A. R., de Vries, P. A. M., Moolenaar, F., de Zeeuw, D., and Meijer, D. K. F. (2001) Potentials and limitations of the low-molecular-weight protein lysozyme as a carrier for renal drug targeting Renal Failure 23, 397-409 10.1081/JDI-100104723
25. Zhou, P., Sun, X., and Zhang, Z. (2014) Kidney-targeted drug delivery systems Acta Pharm. Sin. B 4, 37-42 10.1016/j.apsb.2013.12.005
26. De Groot, A. S. and Scott, D. W. (2007) Immunogenicity of protein therapeutics Trends Immunol. 28, 482-490 10.1016/j.it.2007.07.011
27. Lin, Y.-C., Hung, G.-U., Luo, T.-Y., Tsai, S.-C., Sun, S.-S., Hsia, C.-C., Chen, S.-L., and Lin, W.-Y. (2007) Reducing renal uptake of 111In-DOTATOC: a comparison among various basic amino acids Ann. Nucl. Med. 21, 79-83 10.1007/BF03034003
28. Kaunitz, J. D., Cummins, V. P. S., Mishler, D., and Nagami, G. T. (1993) Inhibition of Gentamicin Uptake into Cultured Mouse Proximal Tubule Epithelial Cells by L-Lysine J. Clin. Pharmacol. 33, 63-69 10.1002/j.1552-4604.1993.tb03905.x
29. Kawai, K., Fujibayashi, Y., Saji, H., Konishi, J., Kubodera, A., and Yokoyama, A. (1990) Monoiodo-d-tyrosine, an artificial amino acid radiopharmaceutical for selective measurement of membrane amino acid transport in the pancreas Int. J. Radiat. Appl. Instrum., Part B. Nucl. Med. Biol. 17, 369-376 10.1016/0883-2897(90)90103-8
30. Xu, B., Shokeen, M., Sudlow, G., Harpstrite, S. E., Liang, K., Cheney, P., Edwards, W. B., Sharma, V., Laforest, R., and Akers, W. et al. 2015, Utilizing the Multiradionuclide Resolving Power of SPECT and Dual Radiolabeled Single Molecules to Assess Treatment Response of Tumors Molecular Imaging and Biology 17, 671-679 10.1007/s11307-015-0842-8
31. Bailey, G. (2002) The Chloramine T Method for Radiolabeling Protein, in Protein Protocols Handbook (Walker, J., Ed.) pp 963-965, Humana Press.
32. Sharma, P. C., Jain, A., Jain, S., Pahwa, R., and Yar, M. S. (2010) Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects J. Enzyme Inhib. Med. Chem. 25, 577-589 10.3109/14756360903373350
33. Christensen, E. I. and Birn, H. (2002) Megalin and cubilin: multifunctional endocytic receptors Nat. Rev. Mol. Cell Biol. 3, 258-68 10.1038/nrm778
34. Yoshida, T. and Nagasawa, T. (2003) ϵ-Poly-l-lysine: microbial production, biodegradation and application potential Appl. Microbiol. Biotechnol. 62, 21-26 10.1007/s00253-003-1312-9
35. Choi, K. Y., Swierczewska, M., Lee, S., and Chen, X. (2012) Protease-activated drug development Theranostics 2, 156-78 10.7150/thno.4068
36. Luzio, J. P., Rous, B. A., Bright, N. A., Pryor, P. R., Mullock, B. M., and Piper, R. C. (2000) Lysosome-endosome fusion and lysosome biogenesis J. Cell Sci. 113 (Pt 9) 1515-24
37. Miller, R. P., Tadagavadi, R. K., Ramesh, G., and Reeves, W. B. (2010) Mechanisms of Cisplatin nephrotoxicity Toxins 2, 2490-518 10.3390/toxins2112490
38. Yao, X., Panichpisal, K., Kurtzman, N., and Nugent, K. (2007) Cisplatin nephrotoxicity: a review Am. J. Med. Sci. 334, 115-24 10.1097/MAJ.0b013e31812dfe1e
39. Leheste, J. R., Rolinski, B., Vorum, H., Hilpert, J., Nykjaer, a., Jacobsen, C., Aucouturier, P., Moskaug, J. O., Otto, a., and Christensen, E. I. et al. 1999, Megalin knockout mice as an animal model of low molecular weight proteinuria Am. J. Pathol. 155, 1361-70 10.1016/S0002-9440(10)65238-8